Are patients with panic disorder respiratory subtype more vulnerable to tobacco, alcohol or illicit drug use? by Freire, Rafael C. & Nardi, Antonio E.
Original article
Are patients with panic disorder respiratory subtype more vulnerable to tobacco, 
alcohol or illicit drug use?
Pacientes com subtipo respiratório do transtorno de pânico são mais vulneráveis ao uso de tabaco, álcool ou 
outras substâncias?
rafael C. freire1, anTonio e. nardi1
1 Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, National Institute for Translational Medicine (INCT-TM), Rio de Janeiro, Brazil.
Institution where the study was conducted: Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, National Institute for Translational Medicine (INCT-TM), 
Rio de Janeiro, Brazil.
Received: 6/13/2012 – Accepted: 4/29/2013
Abstract
Background: Studies have documented high use of tobacco, alcohol and illicit drugs in patients with panic disorder (PD). The comorbid substance use disorders 
worsen the prognosis of mood and anxiety disorders. The respiratory subtype (RS) of PD seems to represent a more severe and distinct form of this disorder 
associated with higher familial history of PD and more comorbidity with other anxiety disorders. Objectives: Describe the patterns of tobacco, alcohol or illicit 
drug use in PD patients, and also to ascertain if patients with the RS use these substances more than those of the non-respiratory subtype. Methods: This is a 
cross-sectional study with 71 PD patients. The Alcohol Use Disorders Identification Test and Fagerstrom Tobacco Questionnaire were used in the evaluation. 
Patients with four or five respiratory symptoms were classified in the RS, the remaining patients were classified as non-respiratory subtype. Results: In our 
sample 31.0% were smokers, 11.3% were hazardous alcohol users and none of them was using illicit drugs. There were no differences between the respiratory and 
non-respiratory subtypes regarding the use of tobacco, alcohol, cannabis, cocaine, stimulants and hallucinogens. Discussion: The RS was not correlated to the 
use of tobacco, alcohol and illicit drugs. Additional epidemiological and clinical studies focusing the relationship between PD and substance use are warranted.
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Resumo
Contexto: Estudos anteriores têm mostrado associações entre o transtorno de pânico (TP) e o uso de tabaco, álcool e substâncias ilícitas. É conhecido que 
transtornos de uso de substâncias interferem negativamente no prognóstico de transtornos de ansiedade e depressão. No subtipo respiratório (SR) do TP há 
mais história familiar de TP e maior risco de comorbidades com transtornos de ansiedade. Objetivos: Descrever os padrões de uso de tabaco, álcool e outras 
substâncias em pacientes com TP. Além disso, analisar se pacientes do SR usam mais essas substâncias do que os pacientes do subtipo não respiratório. Mé-
todos: Esse foi um estudo transversal com 71 pacientes com TP. As escalas Alcohol Use Disorders Identification Test e Fagerstrom Tobacco Questionnaire foram 
aplicadas. Pacientes com quatro ou cinco sintomas respiratórios foram considerados no SR, e os demais pacientes foram considerados como do subtipo não 
respiratório. Resultados: Na amostra estudada, 31,0% dos pacientes eram fumantes, 11,3% faziam uso perigoso de álcool e nenhum fazia uso de substâncias 
ilícitas. Não houve diferença entre os subtipos respiratório e não respiratório em relação a tabagismo, uso de álcool, cannabis, cocaína, estimulantes e aluci-
nógenos. Conclusão: O SR não foi correlacionado com o uso de tabaco, álcool ou drogas ilícitas. Mais estudos clínicos e epidemiológicos focando a relação 
entre o TP e uso de substâncias são necessários.
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Introduction
In the Diagnostic and Statistical Manual of Mental Disorders (DSM-
-IV)1, psychiatric diagnoses are based on clusters of symptoms and 
on characteristics of clinical course rather than on concurrent neu-
robiological mechanisms that are associated with these syndromes. 
According to this classification system, panic disorder (PD) is a 
unitary diagnostic category1. Nevertheless, within this category there 
are diverse clinical presentations, leading to concerns that PD is not 
a singular diagnosis2. As a response to these concerns, alternative 
classiﬁcation schemes have been devised2. Several studies indicated 
that PD patients with prominent respiratory symptoms may repre-
sent a distinct subtype of this disorder3. High rates of alcohol4 and 
cigarette5 use have been found in respiratory subtype patients. The 
use of cannabis6, stimulants, cocaine and hallucinogens7 has been 
correlated to PD but the association between the respiratory subtype 
and the use of these substances has never been investigated.
There is scientific evidence that the “respiratory symptoms” group 
is a distinct PD subtype3,8. Briggs et al.8 studied the descriptions of the 
most recent severe panic attack of 1108 PD patients and performed 
a principal component analysis of the symptoms. The symptoms of 
fear of dying, chest pain/discomfort, shortness of breath, paresthesias, 
and sensation of choking defined a distinct group and the absence 
of these symptoms defined another group. Patients were included 
in the respiratory subtype group if they had four or five of these 
respiratory symptoms during the PA; patients with three or less of 
these symptoms belonged to the non-respiratory subtype. The group 
with prominent respiratory symptoms suffered more spontaneous 
PAs, whereas patients in the non-respiratory subtype depicted more 
situational PAs8.
Recent studies indicate that respiratory subtype patients may 
have higher familial history of PD, lower neuroticism scores, and 
higher scores in severity scales compared to non-respiratory subtype 
patients3,9. Roberson-Nay et al.10 studied the PD respiratory subtype 
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in an epidemiologic sample (n = 2294) and a clinical sample (n = 
1169) and found high temporal stability for the subtype. The authors 
also found higher comorbidity with agoraphobia, social anxiety 
disorder, generalized anxiety disorder and specific phobia for the 
respiratory subtype, compared to the non-respiratory subtype10. In 
two studies with smaller samples11,12 the respiratory subtype was 
associated with low comorbidity with major depressive disorder, but 
in the study of Roberson-Nay et al.10 the opposite was found. There 
were also conflicting findings regarding the duration of the illness5,10. 
High prevalence of respiratory symptoms was found in patients with 
nocturnal PAs or traumatic suffocation history3.
There is a high occurence of smoking in patients with anxiety and 
depressive disorders13,14. Compared to patients with other psychiatric 
disorders, or even with people without psychiatric disorders, a higher 
proportion of PD patients smoke cigarettes15. The temporal pattern 
underlying such a co-occurrence is still a matter of debate. Clinical 
and experimental data suggested that smoking increases the risk of 
new onset PD, but it is also possible that PD precedes smoking. There 
are five different hypotheses to explain the relationship between PD 
and smoking: (a) cigarette smoking may lead to the onset of panic by 
inducing respiratory abnormalities or lung disease – smoking may 
increase the risk of panic because, according to the false suffocation 
alarm theory, it induces an overreaction to suffocation signals; (b) 
nicotine may produce physiologic effects characteristic of panic at-
tacks by promoting the release of norepinephrine into the brainstem; 
(c) smoking may modify the expression of panic disorder by increa-
sing potentially fear-producing bodily sensations – individuals with 
panic disorder who usually perceive themselves as being physically 
unhealthy would more likely react with exaggerated anxiety; (d) pa-
nic disorder patients may smoke as a means of self-medicating their 
symptoms, because of the anxiolytic effects of nicotine or because of 
cognitive mechanisms (smoking narrows the focus of attention and 
diverts one from stressful cognitions). Through this pathway, PD 
would increase the risk of smoking; (e) the co-ocurrance of smoking 
and PD suggest the two problems may share a common vulnerabi-
lity such as neuroticism or other personality features15. Respiratory 
abnormalities are present in both smokers and PD patients16, and 
they are more frequent in the respiratory subtype3 suggesting there 
may be an association between smoking and the respiratory subtype. 
Biber and Alkin5 found a higher proportion of smokers and higher 
cigarette consumption in the respiratory subtype patients compared 
to the non-respiratory subtype.
Concerning the consumption of alcohol, several studies indicate 
there is an association between alcohol use disorders and PD17. Pa-
nic patients may use alcohol as self-medication, while in alcoholics 
alcohol withdrawal may trigger the onset of PD, explaining the 
frequent comorbidity between these two disorders7. Lifetime mari-
juana use was correlated to current and lifetime diagnosis of PD6. 
Although the relationship between cannabis use and PD is not fully 
understood investigators believe that marijuana may be used as an 
attempt of self-medication6. Sareen et al.7 found in anxiety disorder 
patients higher lifetime rates of stimulant, cocaine, hallucinogen and 
heroin use. PD was correlated to the use of stimulants, cocaine and 
hallucinogens, with the highest odds ratio for hallucinogens (3.02 to 
3.62). It is not clear whether there is a causal relationship between 
the use of these illicit drugs and PD or not7. Studies regarding the 
effects of marijuana smoking in pulmonary function yield to con-
flicting results, but the heavy use of marijuana probably decreases 
pulmonary function18. There are also conflicting results concerning 
the effects long-term use of free-base cocaine on respiration19,20. 
There are no studies indicating that the use of alcohol, stimulants and 
hallucinogens produce respiratory abnormalities. Although the use 
of these substances is associated to PD it is probably not associated 
to the respiratory subtype of PD.
The aim of this study is to describe the patterns of tobacco, alcohol 
or illicit drug use in PD patients. The secondary objective is to verify 
if the respiratory subtype patients use more of these substances than 
those in the non-respiratory subtype.
Methods
General practitioners in public clinics and hospitals in Rio de Janeiro 
usually refer PD patients to the LABPR for psychiatric treatment. 
When patients arrived for the first consultation with the psychiatrist, 
they were invited to participate in the current study. Treatment was 
offered to all patients without any cost, regardless the agreement to 
participate in the study.
The present study consists of a cross-sectional study of PD pa-
tients, with ages between 18 and 65. Subjects were enrolled in the 
study’s protocol in their first visit to the Laboratory of Panic and 
Respiration (LABPR) of the Institute of Psychiatry of the Federal 
University of Rio de Janeiro. In this evaluation diagnoses were made 
according to the Mini International Neuropsychiatric Interview 
5.0 (MINI)21,22 and all patients fulfilled DSM-IV1 criteria for PD. 
The diagnoses of comorbid psychiatric disorders, substance abuse, 
or dependence according to the criteria from the MINI were also 
registered. Clinicians rated the Clinical Global Impression (CGI)23 
and registered the respiratory symptoms in the most recent severe 
panic attack. Patients with four or five respiratory symptoms were 
classified in the respiratory subtype, the remaining patients were 
classified as non-respiratory subtype. All subjects filled up a form with 
sociodemographic and clinical data including age, gender, education, 
occupation, familial history of PD and age of onset of PD. Subjects 
were asked if they were currently using or used tobacco, alcohol or 
any illicit drug in the past. Subjects were also asked if the onset of 
smoking preceded PD and if there has been an overlap of PD and 
smoking. All subjects filled the Alcohol Use Disorders Identification 
Test (AUDIT)24 and smokers filled the Fagerström Test for Nicotine 
Dependence (FTND)25, both validated to Brazilian Portuguese26,27. 
Scores of 8 and higher in the AUDIT were considered hazardous 
alcohol use24.
All PD patients were submitted to a complete medical evaluation, 
and those with unstable medical condition, pregnancy, suicide risk, 
bipolar disorder, schizophrenia, delusional or psychotic disorders, 
organic brain syndrome, severe personality disorder or epilepsy were 
not included in the sample.
The local Ethics Committee approved the protocol for this study 
and all patients signed an informed consent before participating in 
the study.
The respiratory subtype patients were compared to the non-
-respiratory subtype patients. The Student’s t test was used to compare 
means of continuous variables between two groups. For categorical 
variables the comparison was made with the chi-square. All analyses 
were two-tailed and the level of statistical significance was set at 5%.
Results
In the sample, there were 71 patients, 67.6% (n = 48) females and 
32.4% (n = 23) males, the mean age was 39.3 (SD = 10.6) years. The 
mean income was 4.9 (SD = 3.3) minimum wages, 70.4% (n = 50) 
were employed, 29.6% (n = 21) had family history of PD and the 
mean age of onset was 33.1 (SD = 10.2) years. The most frequent 
comorbid diagnosis was agoraphobia (71.8%, n = 51), followed by 
major depressive disorder (45.1%, n = 32), generalized anxiety disor-
der (7.0%, n = 5), social anxiety disorder (1.4%, n = 1) and obsessive 
compulsive disorder (1.4%, n = 1). The prevalence of RS was 57.7% 
(n = 41) and the mean CGI score was 4.3 (SD = 0.9).
There were 31.0% (n = 22) smokers and their mean Fagerstrom 
Tobacco Questionnaire score was 5.6 (SD = 2.7). The AUDIT scores 
were low (mean = 2.4, SD = 3.9) and only 31.0% (n = 22) of the 
patients reported drinking alcoholic beverages more than once a 
month. Eight (11.3%) patients had AUDIT score above 7, indica-
ting hazardous alcohol use. Three patients (4.2%) fulfilled criteria 
for substance dependence in 12 months, and there were no other 
substance use disorder diagnoses. One patient was diagnosed with 
stimulant dependence but she stopped taking this substance six 
months before the evaluation. The other two patients were alcohol 
dependent with high AUDIT scores (12 and 19). There was a small 
137Freire RC, Nardi AE / Rev Psiq Clín. 2013;40(4):135-8
prevalence of lifetime use of stimulants (1.4%, n = 1), cocaine (5.6%, 
n = 4), cannabis (11.3%, n = 8) and hallucinogens (1.4%, n = 1), but 
none of the patients were using these substances in the moment of 
the evaluation.
Regarding the timing of smoking and PD, all lifetime smokers 
(46.5%, n = 33) reported that smoking came first. Among lifetime 
smokers 66.7% (n = 22) were currently smoking, 24.2% (n = 8) 
stopped smoking and reported no overlap between smoking and 
PD, 9.1% (n = 3) stopped smoking and reported a period of overlap 
between smoking and PD. Among females 35.4% were current 
smokers while among males there were 21.7% of smokers, but this 
difference was not statistically significant.
In the comparison between the respiratory and non-respiratory 
subtype patients there were few differences. Only 26.8% (n = 11) of 
the RS patients and 36.7% (n = 11) of the non-respiratory subtype 
reported drinking alcoholic beverages more than once a month, but 
this difference did not show statistical significance. The respiratory 
subtype patients had lower employment rates (Chi-square = 4.157, 
1 df, P = 0.041), more comorbid generalized anxiety disorder (Chi-
-square = 3.936, 1 df, P = 0.047) and higher CGI scores (t test, P = 
0.004) compared to the non-respiratory subtype. There was also a 
trend (Chi-square = 3.672, 1 df, P = 0.055) towards higher lifetime 
illicit drug use in the non-respiratory subtype, compared to the 
respiratory subtype (Table 1). There were no statistically significant 
differences between the two subtypes regarding the use of tobacco 
or alcohol.
Discussion
The use of tobacco among PD patients was high, but the use of al-
cohol and illicit drugs were low. Compared to the non-respiratory, 
respiratory subtype patients had lower employment rates, higher 
comorbidity with GAD, higher CGI scores and there was a trend 
towards lower lifetime use of illicit drugs. There were no differences 
between the two groups regarding the use of tobacco, alcohol, co-
caine, cannabis, stimulants and hallucinogens.
In the Brazilian population 17.2% are current smokers and 35.3% 
are lifetime smokers28, while in PD patients 31.0% were current 
smokers and 46.5% were lifetime smokers. The high proportion of 
smokers among PD patients corroborates the evidences indicating 
an association between PD and smoking. However, the present study 
did not show a correlation between smoking and the respiratory 
subtype. There were no differences regarding the prevalence of 
current or lifetime smoking. The degree of nicotine dependence was 
also similar between the two groups. In the study from Biber and 
Alkin5 the respiratory subtype was associated with current smoking 
and high cigarette consumption (pack year). The differences in the 
findings of these two studies may be due to the smaller sample size 
and to the fact that patients with current or past depression were not 
included in Biber and Alkin’s study5. As in most studies exploring 
the relationship between PD and smoking15, smoking preceded PD 
in all lifetime smokers. There is not sufficient data to rule out the 
possibility that the cumulative effect of smoking increases the risk 
of the PD respiratory subtype.
It was estimated that 42% of the Brazilian population consumes 
alcoholic beverages at least once a month, while 58% consumes 
alcohol less than once a month29. A recent study30 indicated that 
24.6% of women consume alcohol during pregnancy, increasing 
the risk of malformations and other problems. Alcohol use is also 
associated with an increased risk of traffic accidents31. In a study 
conducted in Brazil, 20% of the drivers had high alcohol levels in 
the breathanalyzer test and 66% of them reported driving under the 
effect of alcohol at least once31. In our study, few PD patients were 
using alcohol, the mean AUDIT score was low and only 2.8% of the 
patients were alcohol-dependent. Sbrana et al.32 also found low rates 
of alcohol use disorders in a clinical sample of PD patients, with a 
prevalence of 4%. On the other hand, several studies indicate that 
among alcohol-dependent patients the rate of PD is high, ranging 
from 13% to 25%17. The current study did not replicate the results of 
our previous work4 in which the respiratory subtype was correlated 
to previous alcohol use. More studies are needed to explore the rela-
tionship between alcohol use and the respiratory subtype.
Despite the literature indicating high lifetime illicit drug use in 
PD patients, in the current study these rates were low. Previous studies 
indicated that lifetime marijuana use increased the risk for panic 
attacks and PD, also more than a half of the patients with 12-month 
PD were lifetime marijuana users6,33. Sareen et al.7 also found rates 
much higher than those found in the present study, with lifetime 
prevalences of 2.8%-14.9% for stimulants, 4.1%-16.2% for cocaine, 
6.9%-10.7% for hallucinogens and 0.4%-1.4% for heroin in anxiety 
disorder patients. The current study was the first one to explore the 
possible association between illicit drug use and the respiratory 
subtype, and no correlations were found.
The high mean age and the preponderance of females in our 
sample may explain why the rates of alcohol and illicit drug use 
were low. In a sample with a majority of females one might expect a 
low rate of smokers, but female subjects with PD seem to smoke the 
same or more than males with PD14.
The main limitations of this study were the small sample size and 
a possible selection bias. The small sample size led to a low power 
in the statistical tests, increasing the risk of type II errors. In the 
Institute of Psychiatry of the Federal University of Rio de Janeiro, 
patients with a primary problem of substance abuse or dependence 
are usually referred to the Drug Abuse Research and Care Program 
(Programa de Estudos e Assistência ao Uso Indevido de Drogas – 
PROJAD), which is a treatment center for substance use disorders. 
Table 1. Comparison between respiratory and non-respiratory subtypes
 
 
Non-respiratory subtype Respiratory subtype
mean/n SD/% mean/n SD/%
Gender
Male 10 33.3 13 31.7
Female 20 66.7 28 68.3
Age 39.5 11.6 39.2 10.1
Employeda 25 83.3 25 61.0
Agoraphobia 19 63.3 32 78.0
MDD 12 40.0 20 48.8
GADb 0 0 5 12.2
Alcohol dependence* 1 3.3 1 2.4
Stimulant dependence* 0 0 1 2.4
CGIc 3.9 0.8 4.5 0.8
Current substance use
Smoking 9 30.0 13 31.7
FTND** 6.3 2.1 5.1 3.0
AUDIT score 2.7 4.5 2.2 3.4
Hazardous alcohol use*** 5 16.7 3 7.3
Lifetime substance use
Smoking 14 46.7 19 46.3
Alcohol**** 9 30.0 12 29.3
Illicit drugsd 7 23.3 3 7.3
Cocaine 3 10.0 1 2.4
Cannabis 5 16.7 3 7.3
SD: standard deviation; PD: panic disorder; MDD: major depressive disorder; GAD: generalized 
anxiety disorder; CGI: Clinical Global Impression (state); FTND: Fagerstrom Tobacco Questionnaire; 
AUDIT: Alcohol Use Disorders Identification Test.
* Substance dependence in 12 months according to the MINI.
** Among smokers only.
*** Score of 8 or more in the AUDIT.
**** Several times a week.
a Chi-square = 4.157, 1 df, P = 0.041.
b Chi-square = 3.936, 1 df, P = 0.047.
c Student’s t test, P = 0.004.
d Chi-square = 3.672, 1 df, P = 0.055.
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On the other hand, patients with primary anxiety and depression 
are usually referred to the Laboratory of Panic and Respiration. 
Other limitations of this study were that the age of onset and pack 
years were not registered, therefore the cumulative effect of smoking 
could not be assessed. The evaluation of alcohol and illicit drug use 
was also superficial. The authors used only the AUDIT scale to rate 
the alcohol use intensity, no scales for illicit drugs were employed. 
Age of onset, biomarkers and other variables regarding substance 
use were not registered.
In a clinical sample of PD patients, the prevalence of smoking 
was high and the use of alcohol and illicit drugs was low. The use of 
tobacco, alcohol, cannabis, cocaine, stimulants and hallucinogens 
were not correlated to the respiratory subtype of PD. Additional 
epidemiological and clinical studies focusing the relationship 
between PD and the use of tobacco, alcohol and illicit drugs are 
warranted.
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